Abstract:One of the dominant post-translational modifications in mammals is mucin-type (GalNAc-type) O-glycosylation initiated by polypeptide N-acetyl-galactosaminyltransferases (ppGalNAc-Ts), which is closely associated with many physiological and pathological conditions. An atomic-level understanding of the structural dynamics of one critical catalytic loop in ppGalNAc-Ts from an open to a closed state upon substrate binding, however, is still elusive. Here, by constructing a Markov state model based on extensive all-atom molecular dynamics (MD) simulations with an aggregated simulation time of similar to 20 mu s, we reveal, at atomistic resolution, the key metastable states of the catalytic loop in ppGalNAc-T2 during its closing/opening dynamics after donor substrate (UDP-GalNAc) binding. The overall catalytic-loop closing motion is estimated to take place at a timescale of similar to tens of mu s, with the rate-limiting transition caused by some critical structural rearrangements within the catalytic loop region, coupled with the desolvation process. We find that the presence of UDP-GalNAc facilitates the formation of a stable interaction network with several nonloop residues (i.e., L204, V330, H145, and W331), which in turn promotes the loop closing. Moreover, the functional roles of several critical active-site residues were further evaluated through combining site-directed mutagenesis, high-performance liquid chromatography, MS/MS, and mutant MD simulations. It is intriguing to observe that the UDP-GalNAc binding and the following catalysis can tolerate all the tested loop-residue substitutions, some can even profoundly enhance the enzyme efficacy (i.e., H365A and F377A). More importantly, the catalytic loop is found to play a decisive role in regulating the glycosylation-site preferences. Our work provides the structural basis for the key regulatory factors that dictate the substrate loading and following catalysis during mucin-type O-glycosylation.

Molecular Insights into the Regulation of GNPTAB by TMEM251

GCAF(TMEM251) regulates lysosome biogenesis by activating the mannose-6-phosphate pathway

LYSET/TMEM251/GCAF is critical for autophagy and lysosomal function by regulating the mannose-6-phosphate (M6P) pathway

Conformation and Dynamics of the C-terminal Region in Human Phosphoglycerate Mutase 1

TMEM175: A Lysosomal Ion Channel Associated with Neurological Diseases

Structural insights into how GlcNAc-1-phosphotransferase directs lysosomal protein transport

Identification and Characterization of Mouse GTPBP3 Gene Encoding a Mitochondrial GTP-binding Protein Involved in Trna Modification

Identification and Characterization of Mouse MTO1 Gene Related to Mitochondrial Trna Modification.

LYSET/TMEM251- a novel key component of the mannose 6-phosphate pathway

Structure of a truncated human GlcNAc-1-phosphotransferase variant reveals the basis for its hyperactivity

Structure of the human GlcNAc-1-phosphotransferase αβ subunits reveals regulatory mechanism for lysosomal enzyme glycan phosphorylation.

Insights into molecular and cellular functions of the Golgi calcium/manganese-proton antiporter TMEM165

Regulatory Role of One Critical Catalytic Loop of Polypeptide N-Acetyl-Galactosaminyltransferase-2 in Substrate Binding and Catalysis During Mucin-Type O-Glycosylation

TMEM241 is a UDP-N-acetylglucosamine transporter required for M6P modification of NPC2 and cholesterol transport

The Distinct Initiation Sites and Processing Activities of TTLL4 and TTLL7 in Glutamylation of Brain Tubulin.

Structures of liganded glycosylphosphatidylinositol transamidase illuminate GPI-AP biogenesis

TRPML1 gating modulation by allosteric mutations and lipids

Cryo-EM Structures of the Mammalian Endo-Lysosomal TRPML1 Channel Elucidate the Combined Regulation Mechanism

NMT1 and NMT2 Are Lysine Myristoyltransferases Regulating the ARF6 GTPase Cycle

Characterization of the Role of TMEM175 in an in Vitro Lysosomal H+ Fluxes Model.